Compound essential oil microcapsule as well as preparation and application thereof

Through the preparation of compound essential oil microcapsules, the complex of thyme and lemongrass essential oils is used to solve the problems of pungent odor and skin irritation of a single essential oil preservative in cosmetics, achieving efficient and safe antibacterial effects in cosmetics.

CN118874355APending Publication Date: 2024-11-01SHANGHAI INST OF TECH
View PDF 0 Cites 1 Cited by

Patent Information

Application Number
CN202410980349.X
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-07-22
Publication Date
2024-11-01

AI Technical Summary

Technical Problem

The single plant essential oil preservative used in existing cosmetics limits its application in the cosmetics field due to pungent odor and skin irritation problems, and the traditional application method of composite essential oil microcapsules has not been reported.

Method used

Using the preparation method of compound essential oil microcapsules, by combining two essential oils from thyme, oregano, eucalyptus, cloves, lavender, lemongrass or citronella essential oils, using chitosan quaternary ammonium salt and gelatin as wall materials. , microcapsules are prepared by recoagulation method and used in cosmetics.

Benefits of technology

It has achieved the reduction of the concentration of single essential oil, reduced flavor irritation and skin irritation, improved antibacterial value, formed a long-term antibacterial effect, and provided a highly efficient, broad-spectrum and safe natural bactericide.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN118874355A_ABST
    Figure CN118874355A_ABST
Patent Text Reader

Abstract

The invention relates to the technical field of corrosion prevention, in particular to an essential oil microcapsule as well as preparation and application thereof, which is characterized in that composite essential oil is used as a core material, chitosan quaternary ammonium salt and gelatin are used as wall materials, and a complex coacervation method is adopted to prepare the composite essential oil microcapsule, the compound essential oil is obtained by compounding any two of thyme essential oil, origanum vulgare essential oil, folium eucalypti essential oil, clove essential oil, lavender essential oil, lemon grass essential oil and citronella essential oil. Compared with the prior art, the invention has the advantages of high efficiency, broad spectrum, safety, antibacterial property and the like.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The invention relates to the field of antiseptic technology, in particular to an essential oil microcapsule and a preparation and application thereof. Background Art

[0002] Cosmetics occupy an important position in people's daily life. In order to ensure the stability of product performance, antimicrobial substances, namely preservatives, must be added. With the advancement of scientific research, society has been conducting more and more in-depth research on preservatives. Many traditional preservatives have been proven to have certain negative effects and will affect human health. Therefore, plant natural preservative products are welcomed by the market. As more and more natural plant ingredients are added to cosmetics, how to better exert their efficacy is a problem that needs to be solved urgently.

[0003] In the field of cosmetics, relevant studies have confirmed that plant essential oils have multiple functions: preservation, beauty, endocrine regulation, aromatherapy, etc. However, the smells of plant essential oils vary. When used as antibacterial agents, excessive dosage of a single essential oil and pungent smell limit its application in the cosmetics field.

[0004] Chinese patent CN103040718A discloses an antiseptic composition, a preparation method thereof and cosmetics, which determines that the compound of two different plant essential oils, namely thyme essential oil and lemongrass essential oil, has a synergistic antibacterial effect on five common microorganisms in cosmetics, and further microencapsulates the composite essential oil to improve its stability, and finally applies the microcapsule product to the cosmetic system for efficacy research. However, the method of applying the composite essential oil microcapsules to the cosmetic antiseptic system has not been reported. Summary of the invention

[0005] The purpose of the present invention is to overcome the shortcomings of the above-mentioned prior art and provide a compound essential oil microcapsule and its preparation and application. By reasonably mixing several essential oils, a microcapsule basic finished product with antibacterial advantages and long-lasting antibacterial effect is obtained, which provides a more effective, economical and convenient choice for the field of cosmetic preservation.

[0006] The purpose of the present invention can be achieved by the following technical solutions:

[0007] A method for preparing compound essential oil microcapsules, comprising:

[0008] Composite essential oil microcapsules were prepared by complex coacervation method using composite essential oil as core material and chitosan quaternary ammonium salt and gelatin as wall materials.

[0009] The composite essential oil is obtained by compounding any two of thyme, oregano, eucalyptus, clove, lavender, lemongrass or citronella essential oils.

[0010] Furthermore, the composite essential oil is obtained by compounding thyme essential oil and lemongrass essential oil.

[0011] Furthermore, the composite essential oil comprises thyme essential oil and lemongrass essential oil in a compounding ratio of 1-9:9-1.

[0012] Furthermore, the composite essential oil comprises thyme essential oil and lemongrass essential oil in a compounding ratio of 8:2.

[0013] Furthermore, when the composite essential oil microcapsules are prepared by the complex coacervation method, the temperature is 10-45° C. and the time is 2-3 hours.

[0014] Furthermore, the mass ratio of the core material to the wall material is 1:2-3:1.

[0015] Furthermore, the mass ratio of the chitosan quaternary ammonium salt to gelatin is 1:5-2:1.

[0016] A compound essential oil microcapsule is prepared by adopting the above preparation method.

[0017] An application of compound essential oil microcapsules, wherein the compound essential oil microcapsules are used for cosmetic preservation.

[0018] Furthermore, the mass percentage concentration of the compound essential oil microcapsules in the cosmetics is 3-5%.

[0019] Compared with the prior art, the present invention has the following advantages and beneficial effects:

[0020] The core material coated by the microcapsules prepared by the present invention is composed of two plant essential oils, thyme and lemongrass, which have a strong synergistic antibacterial effect after compounding. The concentration of a single essential oil is reduced on the basis of expanding its antibacterial value, reducing its flavor stimulation and skin irritation. At the same time, the formation of the microcapsules enables the essential oil to be slowly released to achieve a long-term antibacterial effect. The microcapsules can be applied to cosmetics to inhibit bacteria and fungi. The microcapsule is a natural bactericide with high-efficiency, broad-spectrum and safe antibacterial effect. BRIEF DESCRIPTION OF THE DRAWINGS

[0021] Figure 1 This is a scanning electron microscope image of the composite essential oil microcapsules prepared in Example 2;

[0022] Figure 2 This is the particle size distribution diagram of the composite essential oil microcapsules prepared in Example 2;

[0023] Figure 3 FITR image of the composite essential oil microcapsules prepared in Example 2;

[0024] Figure 4Stereoscopic microscope observations of the chicken embryo chorioallantoic membrane experiment positive control (a) (b), negative control (c) (d), and deionized water solvent control (g) (h) of the composite essential oil microcapsules prepared in Example 2 after 5 minutes of action;

[0025] Figure 5 Microscopic observations of the chicken embryo chorioallantoic membrane experimental standard substance methylparaben 0.2% (a) (b), 0.3% (c) (d) and 0.4% (g) (h) after 5 minutes of action of the composite essential oil microcapsule prepared in Example 2;

[0026] Figure 6 Scanning electron micrographs of the chicken embryo chorioallantoic membrane experiment of the composite essential oil microcapsules prepared in Example 2 after 5 minutes of action of microcapsules at mass concentrations of 3% (a) (b), 4% (c) (d), 5% (e) (f), 6% (g) (h) and 7% (i) (j). DETAILED DESCRIPTION

[0027] The present invention is described in detail below with reference to the accompanying drawings and specific embodiments.

[0028] The following embodiments are implemented based on the above technical solution of the present invention, and provide detailed implementation methods and specific operation processes, but the protection scope of the present invention is not limited to the following embodiments.

[0029] The following are more detailed implementation cases, which further illustrate the technical solutions of the present invention and the technical effects that can be obtained.

[0030] In the following examples, unless otherwise specified, the present invention has no particular limitation on the sources of the components, and commercially available products known to those skilled in the art may be used.

[0031] In the following examples, the five common microorganisms in cosmetics are Staphylococcus aureus, Escherichia coli, Pseudomonas aeruginosa, Candida albicans and Aspergillus niger.

[0032] Example 1

[0033] This embodiment provides a composite essential oil and its preparation, comprising the following steps:

[0034] (1) First, seven plant essential oils with antibacterial effects on common microorganisms were identified: thyme, oregano, eucalyptus, clove, lavender, lemongrass and citronella essential oils.

[0035] (2) by comparing the sizes of the inhibition zones, three essential oils with the best antibacterial effects were screened out in step (1), namely, thyme, oregano and lemongrass essential oils, and the minimum inhibitory concentrations of the three essential oils in step (2) were determined by a 96-well plate method.

[0036] Among them, the minimum inhibitory concentration of thyme essential oil against five microorganisms is 1 to 16 mg / mL, and in some preferred embodiments, it is 0.125 to 2 mg / mL;

[0037] The minimum inhibitory concentration of oregano essential oil against five microorganisms is 8 to 16 mg / mL, and in some preferred embodiments, it is 2 to 8 mg / mL;

[0038] The minimum inhibitory concentration of lemongrass essential oil against five microorganisms is 4-16 mg / mL, and in some preferred embodiments, is 0.5-2 mg / mL.

[0039] (3) using the chessboard dilution method to measure the combined antibacterial index of the three essential oils in step (2) to determine the synergistic antibacterial relationship between the two essential oils,

[0040] Among them, the combined antibacterial index of thyme essential oil and oregano essential oil against five microorganisms is 0.25 to 1, and in some preferred embodiments, it is 0.25 to 0.5;

[0041] The combined antibacterial index of thyme essential oil and lemongrass essential oil against five microorganisms is 0.25 to 1, and in some preferred embodiments, is 0.25 to 0.375;

[0042] The combined antibacterial index of oregano essential oil and lemongrass essential oil against five microorganisms was 0.625-1.

[0043] Therefore, thyme essential oil and lemongrass essential oil were selected as compound essential oils.

[0044] (4) Thyme essential oil and lemongrass essential oil were mixed in different proportions, and the size of the inhibition zone was measured by filter paper to determine the compound mass ratio. The proportion setting was set according to Table 1:

[0045] Table 1 Formula ratio of compound essential oils

[0046] Group Thyme essential oil Lemongrass essential oil 1 10% 90% 2 20% 80% 3 30% 70% 4 40% 60% 5 50% 50% 6 60% 40% 7 70% 30% 8 80% 20% 9 90% 10% 10 0 0 11 100% 0 12 0 100%

[0047] test:

[0048] 1. Activation of bacteria

[0049] Take several test tubes, fill them with melted culture medium, sterilize them, and place them into a slope with an angle of 15° to the horizontal. Under sterile conditions, use the streak method to transfer the test bacteria (bacteria: Staphylococcus aureus, Escherichia coli and Pseudomonas aeruginosa, molds: yeast and Aspergillus niger) to the corresponding slant culture medium, put them in an incubator, and culture Staphylococcus aureus, Escherichia coli and Pseudomonas aeruginosa for 24 hours at 37°C, and yeast and Aspergillus niger at 28°C for 48 to 72 hours. Use the spread plate counting method to count the number of bacteria on the culture medium;

[0050] The number of bacteria on the culture medium was counted using the spread plate counting method;

[0051] Aspergillus niger was cultured by streak method. Spores were picked up with an inoculation loop and streaked on the slope of a PDA test tube. The spores were revived in a 28°C incubator and subcultured for 2 to 3 generations. The spores were washed with sterile saline, and the spore suspension was collected and counted using a hemocytometer.

[0052] 2. Preparation of bacterial suspension

[0053] Nutrient broth (NB) medium was used for bacteria, and potato dextrose broth (PDB) medium was used for fungi. A certain amount of culture medium was prepared, sterilized, cooled to room temperature for use, and the above bacterial suspension was prepared to a concentration of 10 9 CFU / mL, yeast and spore suspensions were prepared at a concentration of 10 8 CFU / mL.

[0054] 3. Determination of the antibacterial zone of compound essential oils

[0055] Determining the inhibition zones of groups 1-12 can qualitatively analyze the antibacterial sensitivity of each formula ratio to different strains. The filter paper method was used to determine the antibacterial ability of each group against Staphylococcus aureus, Escherichia coli, Pseudomonas aeruginosa, Candida albicans and Aspergillus niger. Prepare φ6mm sterile filter paper and soak it in each extract solution for 2 hours before use. Nutrient agar (NA) medium was used for bacteria, and potato dextrose agar (PDA) medium was used for fungi. After sterilization, sterile culture medium plates were prepared. Dilute the bacterial suspension in the exponential growth phase in step 2 to 10 7 CFU / mL, fungal suspension diluted to 10 6 CFU / mL, take 100 μL to the corresponding culture medium and spread it evenly with a coating rod. Stick the filter paper containing the antibacterial extract on the surface of the agar culture medium. After the bacteria and fungi are cultured under the conditions of step (1) for 24h or 48h, use a vernier caliper to measure and calculate the average diameter of the inhibition zone, and screen the mass ratio with the best antibacterial activity for each strain. The measurement results are shown in Table 2.

[0056] Table 2 Diameters of inhibition zones of groups 1-12 against five microorganisms

[0057]

[0058]

[0059] Note: "+" indicates complete inhibition and sterile growth, and "-" indicates that the substance has no inhibition zone;

[0060] Judgment criteria: inhibition zone ≥15mm is highly sensitive, 10-15mm is moderately sensitive, 7-9mm is lowly sensitive, and no inhibition zone is insensitive.

[0061] According to the results in Table 2, under the condition that the two essential oils are known to have a synergistic effect after compounding, there are significant differences in the antibacterial effects of essential oils in different volume ratios of groups 1-9. The inhibitory effects of the essential oil compound on Staphylococcus aureus and Escherichia coli are completely inhibited, which is equivalent to the single thyme essential oil (group 12), but it is worth noting that the inhibitory effect of lemongrass essential oil on these two test bacteria is greatly increased. For Pseudomonas aeruginosa, the antibacterial effects of groups 1-9 are not much different, and the antibacterial effects of groups 8 and 9 are the best, and there is no significant difference, which are 37.93±1.16mm and 38.16±2.87mm, respectively, which is consistent with the additive relationship between the two for Pseudomonas aeruginosa. For Candida albicans, it can be observed that its antibacterial effect increases with the increase of thyme essential oil volume as a whole, with the best antibacterial effect of group 8 and group 9, and there is no significant difference, which is 53.65 ± 0.82 mm and 52.49 ± 1.45 mm, respectively, reflecting the synergistic effect between the two. The best inhibition volume ratio of Aspergillus niger is group 3 and group 8, and the size of the inhibition zone is 55.67 ± 1.24 mm and 68.18 ± 2.57 mm, respectively, wherein the effect of group 8 is more significant. Therefore, thyme: lemongrass is selected as 8:2 as the final composite volume ratio for the preparation of composite essential oil.

[0062] Example 2

[0063] This embodiment provides a composite essential oil microcapsule and its preparation method, comprising the following steps:

[0064] The composite essential oil prepared in Group 8 in Example 1 was used as the core material, and chitosan quaternary ammonium salt and gelatin were used as the wall materials. The composite essential oil microcapsules were prepared by complex coacervation. The specific process flow is as follows:

[0065] (1) Dissolution of gelatin

[0066] Weigh the gelatin granules into a beaker and add distilled water. Place in a 45°C water bath and stir until the gelatin is completely dissolved. Prepare a 1.5% gelatin aqueous solution, marked as "A".

[0067] (2) Emulsification of chitosan quaternary ammonium salt and compound essential oil

[0068] Weigh 0.4g of chitosan quaternary ammonium salt, add 50mL of distilled water and 1% glacial acetic acid to completely dissolve it. After the chitosan quaternary ammonium salt is completely dissolved, add 0.18g of Tween-80 to completely dissolve it, marked as "B", weigh 1.8g of composite essential oil (wherein, the volume ratio of thyme to lemongrass is 4:1) in a small beaker, add 0.12g of Span-80 to completely dissolve it, marked as "C", then add C to B, and shear emulsify at 2000r / min for 5min.

[0069] (3) Complex coagulation reaction

[0070] The above emulsion was gradually added dropwise to "A", and the pH of the system was adjusted to 5.2-5.4 with 10% NaOH solution. -1 The reaction was repeated at a speed of 30 min.

[0071] (4) Cross-linking and curing

[0072] The above-mentioned complex coagulation suspension was cooled to below 10°C in an ice water bath to terminate the complex coagulation reaction. A 0.8% tannic acid solution prepared and dissolved in advance was slowly added dropwise within 0.5 h, and the mixture was reacted in a constant temperature water bath at 45°C for 2 h at a rotation speed of 500 r / min for solidification, and freeze-dried to obtain the microcapsule powder of this embodiment.

[0073] Take this microcapsule as the test sample and measure the scanning electron microscope: cut a small piece of conductive glue and stick it on the sample stage, spread the dried solid microcapsule powder evenly on the conductive glue, press gently to fix the microcapsule, and then perform gold spraying. Put the treated sample into the scanning electron microscope for observation. Figure 1 This is a scanning electron microscope image of the microcapsules, from which it can be observed that the microcapsules have good morphology, but there is a certain degree of adhesion. The size and morphology of the microcapsules are not significantly different, and they are evenly distributed. The microcapsules have a relatively smooth spherical appearance and no obvious cracks. This shows that the structure of the microcapsules is complete and can well protect the volatile compound essential oil.

[0074] Secondly, the particle size distribution of the microcapsules was determined: the diluted microcapsule dispersion of appropriate concentration was taken and added dropwise to the sample pool. Clean water was selected as the dispersant, and all samples were diluted with deionized water to prevent multiple scattering, and the analysis was performed at 25°C. The nanoparticle size potentiometer was used for measurement. The dispersion index set by the instrument was 1.59, and the analysis model was universal. Figure 2 It is the particle size distribution diagram of microcapsules. It can be seen from the figure that the particle size of the microcapsules is normally distributed with a narrow distribution range. The particle size distribution range is mainly concentrated in 0.393~11.773μm, and the average particle size is 2.11μm, which has good consistency.

[0075] Finally, the Fourier infrared spectrum of the microcapsules was measured: the sample was mixed with potassium bromide at a mass ratio of 1:200 and ground in a mortar, a small amount was taken to start making slices, and then put into the infrared spectrometer for testing. The measurement resolution was 4 cm -1 , ranging from 4,000 to 400 cm -1 Chitosan quaternary ammonium salt, gelatin, blank microcapsules, compound essential oils and compound essential oil microcapsules were tested using Fourier transform infrared spectrometer. The results are as follows Figure 3 As shown, Figure 3 The successful preparation of composite essential oil microcapsules was further verified by analyzing the composite essential oil (a), chitosan quaternary ammonium salt (b), gelatin (c), empty capsules (d) and microcapsules (e). The spectrum of chitosan (HACC) at 1480 cm -1 and 1077cm -1 Characteristic peaks appear at , corresponding to the bending vibration of -CH3 and CN of the quaternary ammonium salt group. + The stretching vibration of the carbonyl C=O skeleton in gelatinamide Ι is at 1636cm -1 A strong absorption peak is produced at the wavelength; in the empty capsule, the above peaks move 1071cm -1 , 1458cm -1 and 1633cm -1 This indicates that there is a strong electrostatic interaction between the microcapsule shells. Comparing the infrared spectra of the composite essential oil and microcapsules, at 1675 cm -1 The conjugated double bond of citral at 1680 cm -1 , at 1587cm -1 And at 1452cm -1 The characteristic peak of thymol in the microcapsule spectrum appears at 1585 cm -1 and 1435cm -1 , empty capsule 1071cm -1 In the microcapsule at 1075cm -1 This indicates that the composite oil has been well encapsulated in the microcapsules.

[0076] Performance test 1:

[0077] The compound essential oil microcapsules prepared in Example 2 were added to cosmetic emulsions and cosmetic cream systems. Based on the mass of the cosmetic emulsions and creams, a 28-day antiseptic challenge experiment was conducted, with the addition amount of the microcapsules set at 3-5wt%.

[0078] Among them, the formula of cosmetic emulsion is shown in Table 3, and the formula of cosmetic cream is shown in Table 4.

[0079] Table 3: Cosmetic emulsion formula

[0080]

[0081] The preparation operation process is as follows:

[0082] (1) Prepare a 1% carbomer aqueous solution in advance for later use;

[0083] (2) Heat phase A and phase B in a water bath to about 85°C, stirring them evenly while heating to ensure they are fully mixed;

[0084] (3) After mixing, slowly add phase A to phase B, stirring evenly while adding, and homogenize with a homogenizer at 10,000 r / min for 5 minutes while hot;

[0085] (4) When the temperature of the AB mixing part drops to 55°C, add phase C.

[0086] Table 4: Cosmetic cream formula

[0087]

[0088] The preparation process is as follows:

[0089] (1) Prepare 1% carbomer aqueous solution in advance;

[0090] (2) Heat phase A and phase B in a water bath to about 85°C, stirring them evenly while heating to ensure they are fully mixed;

[0091] (3) After mixing, slowly add phase A to phase B, stirring evenly while adding, and homogenize with a homogenizer at 10,000 r / min for 5 minutes while hot;

[0092] (4) When the temperature of the AB mixing part drops to 55°C, add phase C.

[0093] This experiment adopts the test method of the Cosmetic, Toilet and Fragrance Association (CTFA). The specific steps are as follows:

[0094] A microbial challenge test with one inoculation for 28 days was performed according to the requirements of CTFA. Weigh 2 portions of 30g of the prepared lotion / cream into sterilized conical flasks, add 0.3mL of mixed bacteria and mixed fungal suspensions respectively, add 106CFU / mL of mixed bacteria and 105CFU / mL of mixed fungi, mix thoroughly, and culture at 37°C and 28°C respectively. Take samples and analyze them on days 0, 7, 14, and 28 after inoculation, and use the plate colony count method to determine the number of microorganisms. When counting, accurately weigh 1g of sample, add it to a conical flask containing 9mL of sterile saline, shake it thoroughly to mix it, and this suspension is a 1:10 dilution, and then dilute it with saline at a ratio of 1:10. Take 10 on days 0, 7, and 14. -3 -10-5 Dilution, 10 on the 21st and 28th days -1 , 10 -2 The dilution plate pouring method was used to count the number of bacteria in the sample. The test results are shown in Tables 5 and 6. Evaluation criteria for CTFA antiseptic challenge test:

[0095] (1) From the 7th day onwards, when the bacteria or fungi are less than 10 CFU / mL, it indicates that the preservative system of the sample has a particularly strong inhibitory effect on microorganisms. Through the challenge test, the product is not easily contaminated by microorganisms during production, storage and use, and is rated as Grade A;

[0096] (2) On the 28th day, when the bacteria or fungi are between 10 and 100 CFU / mL, it indicates that the preservative system of the sample has a strong inhibitory effect on microorganisms. Through the challenge test, the product is not easily contaminated by microorganisms during production, storage and use, and is rated as Grade B;

[0097] (3) On the 28th day, when the bacteria or fungi count is between 100 and 1000 CFU / mL, it indicates that the antibacterial performance of the preservative system is average and can conditionally pass the challenge test. That is, when the protein or other animal and plant material content in the product is not particularly high, and the production sanitary environment meets the requirements and the packaging is not prone to secondary contamination, the anti-mold system can be used. Otherwise, it cannot be used and is rated as C.

[0098] (4) When the bacteria or fungi count is greater than 1000 CFU / mL on the 28th day, it indicates that the antibacterial performance of the preservative system is relatively poor and is considered to have failed the challenge test. This indicates that the preservative system of the sample cannot effectively inhibit the action of microorganisms and the product is easily contaminated by microorganisms during production, storage and use, and is rated D.

[0099] Table 5: Antiseptic challenge results of different concentrations of microcapsules in cosmetic emulsions

[0100]

[0101]

[0102] Table 6: Antiseptic challenge results of microcapsules with different concentrations in cosmetic creams

[0103]

[0104]

[0105] Tables 5 and 6 respectively list the antiseptic effects of the composite essential oil microcapsules of the present invention on cosmetic emulsion and cream systems at a concentration of 1 to 5%.

[0106] As can be seen from Table 5, when no preservatives were added, the contents of bacteria and fungi in the blank group moisturizing lotion continued to grow, and increased by 16.27% and 8.42% respectively after 28 days, which could not reach the required antiseptic challenge level; the antiseptic effect of the microcapsule group showed an increasing grade with the increase of concentration, and it could pass the antiseptic challenge when the content was 3%, and the antiseptic effect was fully achieved when the concentration was further increased to 4% and 5%. On the 7th day, the number of colonies grown was less than 10 CFU / mL, and the antiseptic effect was stronger;

[0107] It can be concluded from Table 6 that the antiseptic levels of different concentrations of different preservatives for bacteria and fungi are basically the same as those of moisturizing lotions, but there are slight differences in the growth number and degree of inhibition. For the bacterial group, the blank group without preservatives still showed an overall upward growth, but the bacterial growth was 25.14% on the 28th day, and the fungal growth of the blank group without preservatives reached 27.89% on the 28th day. In the absence of any preservatives, moisturizing creams are more susceptible to fungal contamination than moisturizing lotions; when the concentration of the microcapsule group is 4%, the bacteria and fungi in the moisturizing cream can be completely inhibited, that is, no obvious colony growth was observed on the 7th day. Therefore, when the concentration of the microcapsule is 3%, the preservation of the cosmetic emulsion cream system can be achieved. When the concentration continues to increase to 4%, there is no obvious growth of bacteria and fungi on the 7th day, and the antibacterial effect is stronger.

[0108] Performance Test 2: Chicken Embryo Chorioallantoic Membrane Test

[0109] The chicken embryo chorioallantoic membrane test (CAM) is an in vitro evaluation method with high sensitivity, simple operation and low laboratory requirements. It can partially replace the rabbit method for the evaluation of cosmetic eye irritation. In order to evaluate the safety of composite essential oil microcapsules, the commonly used traditional chemical preservative methylparaben is used as a reference. Considering that 50% of the composite essential oil microcapsules are non-antibacterial active ingredients, combined with the antiseptic test results of performance test 1, the concentration of microcapsules must reach 3% to have a significant inhibitory effect. Therefore, the mass concentration of microcapsules added in this experiment is 3%-7% (the solvent is water) to test its irritation, and the concentration gradient of methylparaben is 0.2-0.4%. The test method is as follows:

[0110] 1. Egg incubation

[0111] Purchase fresh chicken embryos within 7 days of age and weighing 50-60g, with the air chamber facing upwards, and start incubation at room temperature for 24 hours. Set the incubation temperature of the incubator to (37.5±0.5)℃, the relative humidity of the incubator to (60±10)%, and the turntable frequency to 4 times / h. Check the eggs when they are incubated to 9 days of age. Discard unfertilized, deformed, and other eggs that do not meet the test requirements, and mark the approximate position of the air chamber on the eggshell surface under the illumination of light.

[0112] 2. Preliminary experiment

[0113] Use 3 chicken embryos, take 0.3 mL of the microcapsule stock solution before freeze drying in step (4) of Example 2 as the liquid test substance, observe the CAM reaction immediately after the test substance is applied for 5 minutes, record the observation results, and record the time of bleeding, coagulation and vascular melting and the degree of toxic effect change to the second. After 5 minutes of exposure, remove the surface liquid with a pipette, and then take pictures for observation. If conditions permit, take pictures immediately after the 5-minute exposure and at the beginning of observation.

[0114] 3. Formal test and result observation

[0115] On the 9th day, the experiment was started. Carefully peel off the eggshell part of the air chamber with a dental curved lens, drip a few drops of physiological saline on the surface of the eggshell membrane to fully wet it, pour it out (it can also be sucked out with a rubber-tipped dropper), and carefully remove the outer membrane of the eggshell with tweezers. Make sure that the exposed chick embryo chorioallantoic membrane is intact and not damaged in any way. Use a pipette to suck 0.3mL of liquid test substance and then add it dropwise on the CAM. Try to spread it evenly and make sure that the coverage area of ​​the test sample is at least nearly 50%. Take a picture immediately after adding the sample, and then let it act for 5 minutes. During this period of action, record the time of the reaction, observe and record the time of bleeding, coagulation and vascular melting, and the degree of toxic effect changes, accurate to seconds. The collection of other CAM change information is very useful for further analysis and retrospective research. If necessary, take pictures and save the test pictures. After 5 minutes of action, remove the surface liquid with a pipette, take pictures again, observe and give scores (IS).

[0116] The reaction time method uses the irritation score (IS) method to calculate the results, and the results are rounded to two decimal places.

[0117]

[0118] Note:

[0119] secH is the bleeding time: the average time when bleeding begins to occur on the CAM membrane, in seconds (s);

[0120] secL is the vessel lysis time: the average time when the vessel lysis is observed in the CAM membrane, in seconds (s);

[0121] secC is the coagulation time: the average time for the onset of coagulation observed on the CAM membrane, in seconds (s).

[0122] Based on the IS value calculation results, the irritation was classified and evaluated according to Table 7.

[0123] Table 7: Evaluation of stimulation scoring method results

[0124]

[0125] Figure 4 The results of the control group include positive, negative and solvent control groups.

[0126] The positive sample was 0.4% NaOH solution, the negative sample was 0.9% NaCl solution, the reference substance was 0.2-0.4% methylparaben, and the solvent control was deionized water.

[0127] Table 8 shows the IS values ​​calculated according to the formula based on the experimental record time. Figure 4 (a)-(f) are the blood vessel conditions of the positive control, negative control and solvent control at 0s and 300s after the sample was added.

[0128] Among them, (a) and (b) are the positive control results ((a) is the blood vessel condition at 0s after the sample is added, and (b) is the blood vessel condition at 300s after the sample is added);

[0129] (c) and (d) are negative control results ((c) is the blood vessel condition at 0s after the sample was added, and (d) is the blood vessel condition at 300s after the sample was added);

[0130] (e) and (f) are the control results of deionized water solvent ((e) is the blood vessel condition at 0s after the sample was added, and (f) is the blood vessel condition at 300s after the sample was added).

[0131] Combination Figure 4 As can be seen from (a) and (b) and Table 8, the positive control, 0.4% NaOH, showed extremely strong irritation, with bleeding at 10s, vascular lysis at 29s, coagulation at 76s, and obvious coagulation points after 300s. The IS value was 17.95, which was in line with the expected results of the experiment for the positive control. The negative control, 0.9% NaCl and the solvent control, showed no obvious changes during the observation period, with no bleeding, vascular lysis and coagulation, and the IS value was less than 1, indicating no irritation.

[0132] Figure 5 (a)-(f) show the reference control group, i.e., 0.2-0.4% methylparaben. Figure 5 Combined with the results in Table 8,

[0133] When the concentration of methylparaben was 0.2% ((a) is the blood vessel condition at 0s after the sample was added, (b) is the blood vessel condition at 300s after the sample was added), no changes in the blood vessels were observed, indicating that the sample was non-irritating.

[0134] When the concentration increased to 0.3% ((c) is the blood vessel condition at 0s after the sample was added, and (d) is the blood vessel condition at 300s after the sample was added), bleeding was observed at 240s, and the IS value was 1.02;

[0135] When the concentration increased to 0.4% ((e) is the vascular condition at 0s after the sample was added, and (f) is the vascular condition at 300s after the sample was added), the bleeding time was advanced to 98s, and the IS value was 3.38. However, no vascular melting or coagulation occurred within these two concentration ranges, so both concentrations showed mild irritation.

[0136] Figure 6 (a)-(j) are the in vitro irritation of microcapsules at mass concentrations of 3% to 7%. Combined with Table 8, it can be seen that the microcapsules did not show irritation to CAM at the measured concentrations. There was no significant change in CAM at the 0th and 300th seconds, and the IS values ​​were all below 1, indicating that they were non-irritating. In performance test 1, the concentration of microcapsules needs to reach 3% or above to have an antibacterial effect on the emulsion and cream system of cosmetics, but here the concentration of microcapsules reached 7% and still had no irritation to CAM. Therefore, adding microcapsules coated with essential oils to the cosmetic preservative system can achieve both antiseptic properties and safety.

[0137] Table 8: Chicken embryo chorioallantoic membrane experiment record

[0138]

[0139] In summary, the thyme essential oil and lemongrass essential oil composite microencapsulation prepared by the present invention has excellent antibacterial properties for use in cosmetic preservative systems, and the sizes of the inhibition zones for the five tested bacteria are higher than those of the single essential oils, showing a synergistic effect. When applied to cosmetic emulsion and cream preservative systems, it shows the highest level for both the bacterial group and the fungal group, passes the preservative challenge, and within the allowed range of addition, not only can long-term antibacterial effects be achieved, but also safety can be guaranteed.

[0140] The above description of the embodiments is to facilitate the understanding and use of the invention by those skilled in the art. It is obvious that those skilled in the art can easily make various modifications to these embodiments and apply the general principles described herein to other embodiments without creative work. Therefore, the present invention is not limited to the above embodiments, and improvements and modifications made by those skilled in the art based on the disclosure of the present invention without departing from the scope of the present invention should be within the scope of protection of the present invention.

Claims

1. A method for preparing a composite essential oil microcapsule, characterized in that: include: Composite essential oil microcapsules were prepared by complex coacervation method using composite essential oil as core material and chitosan quaternary ammonium salt and gelatin as wall materials. The composite essential oil is obtained by compounding any two of thyme, oregano, eucalyptus, clove, lavender, lemongrass or citronella essential oils.

2. The method for preparing the composite essential oil microcapsule according to claim 1, characterized in that: The composite essential oil is obtained by compounding thyme essential oil and lemongrass essential oil.

3. The method for preparing the composite essential oil microcapsule according to claim 1, characterized in that: The composite essential oil comprises thyme essential oil and lemongrass essential oil in a mass ratio of 1-9:9-1.

4. The method for preparing the composite essential oil microcapsule according to claim 3, characterized in that: The composite essential oil comprises thyme essential oil and lemongrass essential oil in a compounding ratio of 8:

2.

5. The method for preparing the composite essential oil microcapsule according to claim 1, characterized in that: When the composite essential oil microcapsules are prepared by the complex coacervation method, the temperature is 10-45° C. and the time is 2-3 hours.

6. The method for preparing the composite essential oil microcapsule according to claim 1, characterized in that: The mass ratio of the core material to the wall material is 1:2-3:

1.

7. The method for preparing the composite essential oil microcapsule according to claim 1, characterized in that: The mass ratio of the chitosan quaternary ammonium salt to gelatin is 1:5-2:

1.

8. A composite essential oil microcapsule, characterized in that: The method is described in any one of claims 1 to 7.

9. An application of the compound essential oil microcapsule as claimed in claim 8, characterized in that: The compound essential oil microcapsule is used for cosmetic preservation.

10. The use of the compound essential oil microcapsule according to claim 9, characterized in that: The mass percentage concentration of the compound essential oil microcapsules in cosmetics is 3-5%.

Citation Information

Cited By

  • Foeniculum vulgare essential oil microcapsule and preparation method thereof

    CN121406401A